Abstract
The incidence and type of allergic reactions to antilymphoblast globulin (ALG) and their relationship to skin testing, histamine release, and serum levels of ALG and anti-ALG antibodies were studied prospectively in 50 patients receiving high-dose ALG therapy intravenously for the first two weeks after renal transplantation. No clinically apparent allergic reactions occurred in the patients studied.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1729-1731 |
| Number of pages | 3 |
| Journal | JAMA: The Journal of the American Medical Association |
| Volume | 236 |
| Issue number | 15 |
| DOIs | |
| State | Published - Oct 11 1976 |